Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.

The purpose of this study was to determine the influence of a controlled incremental increase in size, molecular weight and number of amine, carboxylate and hydroxyl surface groups in several series of poly(amidoamine) (PAMAM) dendrimers for controlled ocular drug delivery. The duration of residence time was evaluated after solubilization of several series of PAMAM dendrimers (generations 1.5 and 2-3.5 and 4) in buffered phosphate solutions containing 2 per thousand (w/v) of fluorescein. The New Zealand albino rabbit was used as an in vivo model for qualitative and quantitative assessment of ocular tolerance and retention time after a single application of 25 microl of dendrimer solution to the eye. The same model was also used to determine the prolonged miotic or mydriatic activities of dendrimer solutions, some containing pilocarpine nitrate and some tropicamide, respectively. Residence time was longer for the solutions containing dendrimers with carboxylic and hydroxyl surface groups. No prolongation of remanence time was observed when dendrimer concentration (0.25-2%) increased. The remanence time of PAMAM dendrimer solutions on the cornea showed size and molecular weight dependency. This study allowed novel macromolecular carriers to be designed with prolonged drug residence time for the ophthalmic route.

[1]  P. Sado,et al.  Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.

[2]  J. Baum,et al.  Decreased Tear Osmolarity and Absence of the Inferior Marginal Tear Strip After Sleep , 1992, Cornea.

[3]  P. Couvreur,et al.  Liposomes Dispersed Within a Thermosensitive Gel: A New Dosage Form for Ocular Delivery of Oligonucleotides , 1998, Pharmaceutical Research.

[4]  S. Benita,et al.  Pilocarpine hydrochloride liposomes: characterization in vitro and preliminary evaluation in vivo in rabbit eye. , 1984, Journal of microencapsulation.

[5]  A. Rozier,et al.  Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol , 1989 .

[6]  T. Vandamme Microemulsions as ocular drug delivery systems: recent developments and future challenges , 2002, Progress in Retinal and Eye Research.

[7]  William A. Goddard,et al.  Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .

[8]  J. Hadgraft,et al.  Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles , 1992, Pharmaceutical Research.

[9]  Kuldeep Singh,et al.  Liposomal ophthalmic drug delivery system I. Triamcinolone acetonide , 1983 .

[10]  G. Smolin,et al.  Idoxuridine-liposome therapy for herpes simplex keratitis. , 1981, American journal of ophthalmology.

[11]  R. Duncan,et al.  Evaluation of the biological properties of soluble chitosan and chitosan microspheres , 1997 .

[12]  John. Mitchell Applied polymer analysis and characterization , 1987 .

[13]  Steven E. Keinath,et al.  Rheology of Dendrimers. I. Newtonian Flow Behavior of Medium and Highly Concentrated Solutions of Polyamidoamine (PAMAM) Dendrimers in Ethylenediamine (EDA) Solvent , 1998 .

[14]  Kinam Park,et al.  Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[16]  D. Bedeaux,et al.  The Viscosity of Solutions of Poly(propylene imine) Dendrimers in Methanol. , 2001, Journal of colloid and interface science.

[17]  J. Gallo,et al.  A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength , 1990, Pharmaceutical Research.

[18]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Shulin Ding RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY , 1998 .

[20]  V. H. Lee,et al.  Effects of topically applied liposomes on disposition of epinephrine and inulin in the albino rabbit eye , 1983 .

[21]  J. Robinson,et al.  Ocular evaluation of polyvinyl alcohol vehicle in rabbits. , 1975, Journal of pharmaceutical sciences.

[22]  G. Kallos,et al.  Molecular weight determination of a polyamidoamine Starburst polymer by electrospray ionization mass spectrometry , 1991 .

[23]  Clive G. Wilson,et al.  Treatment of diseases of the eye with mucoadhesive delivery systems , 1993 .

[24]  I. Kellaway,et al.  Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system , 1992 .

[25]  T. Vandamme,et al.  Controlled release of levamisole from poly-(ε-caprolactone) matrices II. Effects of water-soluble polymer and iron powder incorporated into the matrices , 1996 .

[26]  N. Peppas,et al.  Measurement of the surface tension of mucin solutions , 1989 .

[27]  Kuldeep Singh,et al.  Liposomal ophthalmic drug delivery system. II. Dihydrostreptomycin sulfate , 1984 .

[28]  S. Jain,et al.  A PEGylated dendritic nanoparticulate carrier of fluorouracil. , 2003, International journal of pharmaceutics.

[29]  A. Ludwig,et al.  Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  S. Mishima,et al.  SOME PHYSIOLOGICAL ASPECTS OF THE PRECORNEAL TEAR FILM. , 1965, Archives of ophthalmology.

[31]  N. McKeown,et al.  Polyamidoamine Starburst dendrimers as solubility enhancers. , 2000, International journal of pharmaceutics.

[32]  L. Packer,et al.  Progress in Membrane Biotechnology , 1991, ALS Advances in Life Sciences.

[33]  R. Gurny,et al.  Aqueous nanodispersions prepared by a salting-out process , 1992 .

[34]  J. Robinson,et al.  Bioadhesive and phase-change polymers for ocular drug delivery , 1995 .